a public good project by the
Synthesis
Company
of California

© 2026

Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment | doi.page

0 citations0 references

Google Scholar doi.org

Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment

European Journal of Cancer·2004·Vol. 41(2), pp. 199–205

Citations Over TimeTop 10% of 2004 papers

Karin Jordan, Christoph Kasper, Hans‐Joachim Schmoll

Related Papers

→ Efficacy of aprepitant among patients aged 65 and over receiving moderately to highly emetogenic chemotherapy: A meta-analysis of unpublished data from previously published studies(2012)18 cited
→ Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia(2017)3 cited
→ Granisetron as antiemetic therapy in children with cancer(1995)22 cited
[Antiemetic efficacy of granisetron in the treatment of pediatric cancer--(1). Clinical evaluation of granisetron at a dose of 40 micrograms/kg].(1993)
Application of antiemetic Granisetron during cancer chemotherapy(2011)